RECRUITING

BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

An observational study of electronic patient data to compare diabetes medications and to determine which ones offer the best balance of risks and benefits.

Official Title

BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

Quick Facts

Study Start:2021-07-01
Study Completion:2024-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05161429

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:30 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Emma Hegermiller, MS
CONTACT
617-732-5661
emma@bestmed.org
Alexander Turchin, MD, MS
CONTACT
617-732-5661
aturchin@bwh.harvard.edu

Principal Investigator

Alexander Turchin, MD, MS
PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital

Study Locations (Sites)

HealthCore, Inc.
Wilmington, Delaware, 19801
United States
Humana
Lexington, Kentucky, 40512-4611
United States
Brigham and Women's Hospital
Boston, Massachusetts, 02115
United States
Greater Plains Collaborative
Beachwood, Ohio, 44122
United States
Baylor Scott & White
Dallas, Texas, 75246
United States

Collaborators and Investigators

Sponsor: Brigham and Women's Hospital

  • Alexander Turchin, MD, MS, PRINCIPAL_INVESTIGATOR, Brigham and Women's Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-07-01
Study Completion Date2024-06-30

Study Record Updates

Study Start Date2021-07-01
Study Completion Date2024-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Diabetes Mellitus, Type 2